Published in J Matern Fetal Neonatal Med on May 01, 2007
A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med (2009) 14.40
Maternal and perinatal outcomes associated with a trial of labor after prior cesarean delivery. N Engl J Med (2004) 9.62
Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med (2003) 9.57
Timing of elective repeat cesarean delivery at term and neonatal outcomes. N Engl J Med (2009) 6.86
Preventing preterm births: analysis of trends and potential reductions with interventions in 39 countries with very high human development index. Lancet (2012) 6.33
A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med (2011) 6.11
A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med (2008) 5.11
Preventing the first cesarean delivery: summary of a joint Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-Fetal Medicine, and American College of Obstetricians and Gynecologists Workshop. Obstet Gynecol (2012) 4.63
Fetal pulse oximetry and cesarean delivery. N Engl J Med (2006) 4.45
Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol (2006) 3.87
Vitamins C and E to prevent complications of pregnancy-associated hypertension. N Engl J Med (2010) 3.81
The 2008 National Institute of Child Health and Human Development workshop report on electronic fetal monitoring: update on definitions, interpretation, and research guidelines. Obstet Gynecol (2008) 3.67
Pregnancy outcomes with weight gain above or below the 2009 Institute of Medicine guidelines. Obstet Gynecol (2013) 3.46
Decision-to-incision times and maternal and infant outcomes. Obstet Gynecol (2006) 3.15
A phase I study of low-pressure hyperbaric oxygen therapy for blast-induced post-concussion syndrome and post-traumatic stress disorder. J Neurotrauma (2011) 2.98
The relationship between maternal glycemia and perinatal outcome. Obstet Gynecol (2011) 2.96
A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. N Engl J Med (2007) 2.73
Single versus weekly courses of antenatal corticosteroids: evaluation of safety and efficacy. Am J Obstet Gynecol (2006) 2.69
Fetal injury associated with cesarean delivery. Obstet Gynecol (2006) 2.61
Risk of impaired renal function after colonoscopy: a cohort study in patients receiving either oral sodium phosphate or polyethylene glycol. Am J Gastroenterol (2007) 2.44
Proteomic identification of serum peptides predicting subsequent spontaneous preterm birth. Am J Obstet Gynecol (2010) 2.37
Long-term outcomes after repeat doses of antenatal corticosteroids. N Engl J Med (2007) 2.30
The 2008 National Institute of Child Health and Human Development workshop report on electronic fetal monitoring: update on definitions, interpretation, and research guidelines. J Obstet Gynecol Neonatal Nurs (2008) 2.28
Relationship between 17-hydroxyprogesterone caproate concentrations and gestational age at delivery in twin gestation. Am J Obstet Gynecol (2012) 2.24
Development of a nomogram for prediction of vaginal birth after cesarean delivery. Obstet Gynecol (2007) 2.19
Placenta previa: distance to internal os and mode of delivery. Am J Obstet Gynecol (2009) 2.19
The Maternal-Fetal Medicine Units cesarean registry: chorioamnionitis at term and its duration-relationship to outcomes. Am J Obstet Gynecol (2004) 1.75
Prediction of uterine rupture associated with attempted vaginal birth after cesarean delivery. Am J Obstet Gynecol (2008) 1.70
First-trimester prediction of preeclampsia in nulliparous women at low risk. Obstet Gynecol (2012) 1.66
Risk of uterine rupture with a trial of labor in women with multiple and single prior cesarean delivery. Obstet Gynecol (2006) 1.65
Pregnancy outcomes in women with thyroid peroxidase antibodies. Obstet Gynecol (2010) 1.64
Pregnancy in women with physical disabilities. Obstet Gynecol (2011) 1.60
Risk-adjusted models for adverse obstetric outcomes and variation in risk-adjusted outcomes across hospitals. Am J Obstet Gynecol (2013) 1.54
Timing of elective repeat cesarean delivery at term and maternal perioperative outcomes. Obstet Gynecol (2011) 1.54
The MFMU Cesarean Registry: factors affecting the success of trial of labor after previous cesarean delivery. Am J Obstet Gynecol (2005) 1.54
Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension. Clin Chem (2006) 1.51
17 alpha-hydroxyprogesterone caproate to prevent prematurity in nulliparas with cervical length less than 30 mm. Am J Obstet Gynecol (2012) 1.49
Emerging concepts in antibiotic prophylaxis for cesarean delivery: a systematic review. Obstet Gynecol (2009) 1.48
Perinatal significance of isolated maternal hypothyroxinemia identified in the first half of pregnancy. Obstet Gynecol (2007) 1.46
Performance of ThinPrep liquid-based cervical cytology in comparison with conventionally prepared Papanicolaou smears: a quantitative survey. Gynecol Oncol (2003) 1.45
Amniotic fluid index and birth weight: is there a relationship in diabetics with poor glycemic control? Am J Obstet Gynecol (2006) 1.43
Chronic nicotine differentially regulates alpha6- and beta3-containing nicotinic cholinergic receptors in rat brain. J Pharmacol Exp Ther (2007) 1.42
A randomized controlled trial of prophylactic maneuvers to reduce head-to-body delivery time in patients at risk for shoulder dystocia. Obstet Gynecol (2003) 1.42
Prenatal treatment prevents learning deficit in Down syndrome model. PLoS One (2012) 1.41
QTc interval prolongation associated with intravenous methadone. Pain (2003) 1.40
Comparison of transverse and vertical skin incision for emergency cesarean delivery. Obstet Gynecol (2010) 1.39
Food allergy as a risk factor for life-threatening asthma in childhood: a case-controlled study. J Allergy Clin Immunol (2003) 1.38
Outcomes of induction of labor after one prior cesarean. Obstet Gynecol (2007) 1.34
Prothrombin gene G20210A mutation and obstetric complications. Obstet Gynecol (2010) 1.34
The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus. Obstet Gynecol (2005) 1.33
Teaching rational prescribing: a new clinical pharmacology curriculum for medical schools. Naunyn Schmiedebergs Arch Pharmacol (2002) 1.29
Progesterone receptor polymorphisms and clinical response to 17-alpha-hydroxyprogesterone caproate. Am J Obstet Gynecol (2011) 1.28
Failed operative vaginal delivery. Obstet Gynecol (2009) 1.27
Comparison of maternal and infant outcomes from primary cesarean delivery during the second compared with first stage of labor. Obstet Gynecol (2007) 1.24
Pharmacokinetics of 17-hydroxyprogesterone caproate in multifetal gestation. Am J Obstet Gynecol (2011) 1.24
Second-stage labor duration in nulliparous women: relationship to maternal and perinatal outcomes. Am J Obstet Gynecol (2009) 1.23
Excessive early gestational weight gain and risk of gestational diabetes mellitus in nulliparous women. Obstet Gynecol (2012) 1.20
Effect of arsenic trioxide on QT interval in patients with advanced malignancies. J Clin Oncol (2003) 1.20
Failed labor induction: toward an objective diagnosis. Obstet Gynecol (2011) 1.18
We don't know what we don't study: the case for research on medication effects in pregnancy. Am J Med Genet C Semin Med Genet (2011) 1.16
Putting the "M" back in maternal-fetal medicine. Am J Obstet Gynecol (2012) 1.14
Large uterine leiomyomata and risk of cesarean delivery. Obstet Gynecol (2007) 1.14
Sample bias among women with retained DNA samples for future genetic studies. Obstet Gynecol (2006) 1.14
Perioperative morbidity and mortality among human immunodeficiency virus infected women undergoing cesarean delivery. Obstet Gynecol (2007) 1.13
The frequency of peptic ulcer as a cause of upper-GI bleeding is exaggerated. Gastrointest Endosc (2004) 1.11
The MFMU Cesarean Registry: impact of time of day on cesarean complications. Am J Obstet Gynecol (2006) 1.09
Maternal serum interleukin-6, C-reactive protein, and matrix metalloproteinase-9 concentrations as risk factors for preterm birth <32 weeks and adverse neonatal outcomes. Am J Perinatol (2010) 1.08
Blood transfusion and cesarean delivery. Obstet Gynecol (2006) 1.08
Maternal and neonatal outcomes of repeat cesarean delivery in women with a prior classical versus low transverse uterine incision. Am J Perinatol (2010) 1.07
Risks of induction of labour in women with a uterine scar from previous low transverse caesarean section. BJOG (2004) 1.06
Maternal insulin resistance and preeclampsia. Am J Obstet Gynecol (2011) 1.06
Cesarean delivery on maternal request: obstetrician-gynecologists' knowledge, perception, and practice patterns. Obstet Gynecol (2007) 1.05
Prevention of preterm birth in triplets using 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial. Obstet Gynecol (2009) 1.05
Therapy for hypoxic ischemic encephalopathy: a cool idea. Obstet Gynecol (2005) 1.05
Electronic fetal heart rate monitoring: another look. Obstet Gynecol (2008) 1.05
A neuroprotective peptide antagonizes fetal alcohol exposure-compromised brain growth. J Mol Neurosci (2004) 1.04
Are women with recurrent spontaneous preterm births different from those without such history? Am J Obstet Gynecol (2006) 1.04
Is body mass index an independent risk factor of survival among patients with endometrial cancer? Am J Clin Oncol (2007) 1.03
The MFMU Cesarean Registry: uterine atony after primary cesarean delivery. Am J Obstet Gynecol (2005) 1.02
Can a prediction model for vaginal birth after cesarean also predict the probability of morbidity related to a trial of labor? Am J Obstet Gynecol (2008) 1.02
Risk factors for cervical insufficiency after term delivery. Am J Obstet Gynecol (2006) 1.02
Obstetric cholestasis: outcome with active management. Eur J Obstet Gynecol Reprod Biol (2002) 1.01
Pregnancy outcomes for women with placenta previa in relation to the number of prior cesarean deliveries. Obstet Gynecol (2007) 1.00
The frequency and complication rates of hysterectomy accompanying cesarean delivery. Obstet Gynecol (2009) 1.00
Perioperative antibiotic prophylaxis for nonlaboring cesarean delivery. Obstet Gynecol (2009) 1.00
Novel peptides prevent alcohol-induced spatial learning deficits and proinflammatory cytokine release in a mouse model of fetal alcohol syndrome. Am J Obstet Gynecol (2005) 1.00
Vaginal birth after cesarean: new insights manuscripts from an NIH Consensus Development Conference, March 8-10, 2010. Semin Perinatol (2010) 1.00
Maternal 25-hydroxyvitamin d and preterm birth in twin gestations. Obstet Gynecol (2013) 0.99
Maternal BMI, glucose tolerance, and adverse pregnancy outcomes. Am J Obstet Gynecol (2012) 0.99
Vitamin C and E supplementation to prevent spontaneous preterm birth: a randomized controlled trial. Obstet Gynecol (2010) 0.99
Importance of timing of gestational exposure to methotrexate for its teratogenic effects when used in setting of misdiagnosis of ectopic pregnancy. Fertil Steril (2011) 0.99
Peptide antagonists of ethanol inhibition of l1-mediated cell-cell adhesion. J Pharmacol Exp Ther (2002) 0.99
Risk of further decline in renal function after the use of oral sodium phosphate or polyethylene glycol in patients with a preexisting glomerular filtration rate below 60 ml/min. Am J Gastroenterol (2008) 0.98
Does information available at admission for delivery improve prediction of vaginal birth after cesarean? Am J Perinatol (2009) 0.97
Protective peptides that are orally active and mechanistically nonchiral. J Pharmacol Exp Ther (2004) 0.97
Intraventricular hemorrhage and periventricular leukomalacia in preterm infants. Obstet Gynecol (2004) 0.97